Kezar Life Sciences, Inc.
KZR • NASDAQ
Kezar Life Sciences, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Christopher J. Kirk, with a market cap of $53.7M.
Market Cap$53.7M
Employees58.0
CEOChristopher J. Kirk
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 12, 2026 · In 2 weeksBefore Market Open · Q1 2026
Financials
Kezar Life Sciences, Inc. FAQ
Common questions about Kezar Life Sciences, Inc.
Kezar Life Sciences, Inc. is scheduled to report earnings for Q1 2026 on May 12, 2026 before market open. Analysts estimate revenue of $500.0K.
Kezar Life Sciences, Inc. has approximately 58 employees.